Member Info for stevenc72

Interesting! I have just posted on the DUKE BB - First poster - yay! If AUCT delivers, I might put some into DUKE but more info is needed. Steve

Hi Trevally, Daft question I know, but do you have any expectations on what a stellar deal might mean shareprice wise. I am hoping for pounds rather than pence! Steve

AGM on the 30th. I am expecting some news to tie in with this date, so either end of this week or start of next week. Hoping for big things here.

Hi. Well, the RTO has happened. I sold out at a loss a few months back after making multiple calls into the office and receiving no response. Common courtesy in my opinion costs nothing and there is no excuse for this. I did not even receive an acknowledgement that my calls had been received. Unprofessional, hence the decision to sell. Reading the RNS it looks to me as: Old BoD out Board of GIS in OCT investments to be sold as soon as possible Focus on GIS core activities Cost for us PI's post consolidation 2p per share. This may be a good long term investment given previous levels of GIS growth (but is it sustainable?). I will keep an eye out for the next RNS and may buy back in if it goes below 2p at any point. I don't buy all the 'dividend' tweeting personally. Regards Steve

They seem happy enough given the content of the RNS, which is available on the 3legs RNS page (above). This is well worth keeping an eye on. Potentially some great things to happen here given todays news. One to accumulate I suspect.

RTO for Mediqventures? Mediqventures was founded to identify, finance, and develop promising technologies in the life sciences. Mediqventures provides equity financing either directly to portfolio companies or to single-asset collaborations with existing companies. Mr. Mellon and Mr. Bailey are both Partners in Mediqventures. Steve

Companies...Lots of interesting information! "Jim Mellon wants to put his theory that British and European biotechs are undervalued to the test. The famed investor is trying to raise up to £100 million ($150 million) for a new fund dedicated to small biotechs in the United Kingdom and the rest of Europe. Mellon made a mint in Russia and emerging markets in the 1990s--his estimated wealth is now around £800 million--but in recent years he has become increasingly vocal about biotechs. The 2012 book "Cracking The Code"--which Mellon co-authored with Al Chalabi--was based on the hypothesis that biotech is "the single biggest trend to affect mankind ... and there are fortunes to be made." Now, Mellon is working to raise £50 to £100 million to capture a slice of the gold rush. "There is nothing in the U.K. like this. It is going to invest purely in small biotech companies in the U.K. and Europe," Mellon told FT Advisor. Charlemagne Capital--the investment group Mellon founded and now serves as nonexecutive director--already has a fund comprised of major biopharma companies with "fortress-like balance sheets [and] solid dividend payouts." And Mellon intends to put the head of the Big Pharma fund--Andy Smith--in charge of the new biotech investment vehicle." Source: Fierce Biotech dot com Feb 3 2015

"Following the Subscription and Board appointments, the Directors will propose a resolution at the next Annual General Meeting to change the Company's investing policy to focus on the life sciences sector." Seems to me to be a move away from natural resources/oil and gas. Steve

http://www.forbes.com/sites/ilyapozin/2014/12/17/15-social-media-companies-to-watch-in-2015/ Steve

Always been a relatively quiet board compared to others I could mention. I think everyone is waiting now for the acquisition target news. With the AGM planned for the 30th, I am assuming news (hopefully very positive) will be released just before or maybe just after. After the disappointment of the cancellation of the main listing, some will no doubt be looking for something exceptional here. Lots have invested here due to the quality of the BoD and they are all still actively involved and are seeking reelection at the AGM. Hopefully they can bring home the bacon! Any ideas on possible targets? Steve

Oneandonly1, what do we all know is now coming?

Agreed, hopefully not long now. Steve

From RNS dated 22nd April 2015: "It is anticipated that the newly enlarged entity will be admitted to trading on AIM during Q2 2015." I think our financial year starts 1st January so, in theory, anytime before the end of June. Regards Steve

Well, I sincerely hope it does not follow the example set by Cleeve Capital. They re-listed today under the new ticker 'SAT' (not SSW) and are currently down 18.75%.! Hopefully we will have an altogether more positive experience! Time will tell I suppose. Regards Steve

Thanks. Will do.

Does anyone have any experience of being in a share that is suspended pending RTO announcement details? I am thinking of putting a limit sell order on the shares I hold but really have no idea how to put any sort of valuation on this and do not have the experience of some on the BB. Would anyone be willing to share any thoughts? Regards Steve

There certainly would be a time saving for the RTO instead of the hassle of an IPO, plus associated (minimal?) cost savings. Where did the tinder suggestion come from?...plenty of chatter on Google re. tinder valuation if you type in 'tinder company valuation'. Valuations seem to range from $0 to anywhere up to £5billion. Also appears that the ownership structure is extremely complicated. Steve

This was always a quiet board. There are a few holding though, just waiting for news now on who the target is and the detail of what they actually do. I agree it is exciting and am hoping for a good rise on readmission. I expect no more than a couple of months to sort the RTO out.

Did this jump at the end of trading? My Portfolio is showing a SP of "0.00375 GBP".

I don't suppose they can say much while the current work is being undertaken. I wouldn't take that as a negative! Steve